Unmasking of tuberculosis following antiviral therapy for hepatitis C;Rôle protecteur accidentel de l'interféron alpha contre mycobacterium tuberculosis au cours d'un traitement anti-viral C

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 6-7 I, 2004, Pages 609-610

  Nahon, Pierre ^a   Brugiere, Olivier ^a   Marcellin, Patrick ^a   Valla, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; DISEASE EXACERBATION; ERADICATION THERAPY; HEPATITIS C; HUMAN; MYCOBACTERIUM TUBERCULOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 3142762923     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)95020-8     Document Type: Article

References (9)

1. Appelberg. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and Mycobacterium avium infections. Immunobiology 1994;191:520-5.
2. Onwubalili JK, Scott GM, Robinson JA. Deficient immune interferon production in tuberculosis. Clin Exp Immunol 1985;59:405-13.
3. Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4 T cells. J Exp Med 1993;178:1655-63.
4. Condos R, Rom WN, Schluger NW. Treatment of multi-drug-resistant pulmonary tuberculosis with interferon gamma via aerosol. Lancet 1997;349:1513-15.
5. Giosue S, Casarini M, Alemanno L, Galluccio G, Mattia P, Pedicelli G, et al. Effects of aerosolized interferon alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 1998;158:1156-62.
6. Giosue S, Casarini M, Ameglio F, Zangrilli P, Palla M, Altieri A, et al. Aerosolized interferon alpha treatment in patients with multi-drug-rsistant pulmonary tuberculosis. Eur Cytokine Netw 2000;11:99-103.
7. Palmero D, Eiguchi K, Rendo P, Zorrilla L, Abbate E, Montaner LJ. Phase II trial recombinant interferon alpha 2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. Int J Tuberc Lung Dis 1999;3:2 4-8.
8. MacQuillan GC, Mamotte C, Reed WD, Jeffrey GP, Allan JE. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection. J Med Virol 2003;70:219-27.
9. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000;118:346-55.